-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ankylosing spondylitis (AS) is a chronic inflammatory disease that mainly affects the sacroiliac joints, spinal joints and other axial joints.
The researchers searched PubMed, Cochrane and Embase for related studies published before November 2019.
A total of 9 studies were included, including 6,363 patients.
In summary, the results of this study show that golimumab has a certain effect on the treatment of AS.
Original source:
Jami Sayed Abdulla, et al.
ncbi.
nlm.
nih.
gov/32447529/" target="_blank" rel="noopener">Patients with ankylosing spondylitis treatment by golimumab: a systematic review and meta-analysis
in this message